The global lung cancer screening software market size is estimated to reach
USD 37.92 million by 2025 expanding at a CAGR of 19.5% from 2019 to 2025,
according to a new report by Grand View Research, Inc. Growing incidence of
lung cancer and rise in implementation of lung cancer screening programs across
the globe are some of the significant factors driving the market growth.
According to Globocan estimates, about 160,068 new cases of lung cancer were
reported in South East Asian region in 2018.
A number of clinical trials, studies, and
demonstration projects are being conducted around the world to evaluate the
effectiveness of lung cancer screening programs. For instance, in 2017, Cancer
Care Ontario launched a screening pilot trial for people at high risk.
Favorable government initiatives for successful implementation of such programs
and increasing awareness about the disease screening are also likely to
contribute to the market growth in the coming years.
Lung cancer screening programs are widely
adopted by hospitals and radiological centers in U.S. However, they are usually
performed as a part of national or provisional screening program outside the
country. In case of Latin America and Middle Eastern countries, limited
availability of resources, restricted funding, low awareness levels, and lack
of trained personnel are some of the factors that impede market growth.
Access Research Report of Lung Cancer
Screening Software Market @ https://www.grandviewresearch.com/industry-analysis/lung-cancer-screening-software-market
Further key findings from the study suggest:
· In 2018, North America accounted for the
highest revenue share owing to various lung cancer screening programs and
favorable reimbursement scenario in the region
· Asia Pacific is expected to be the
fastest-growing regional market over the forecast period
· This is attributed to the increasing cases
of lung cancer and rise in the number of screening trials & studies for the
disease
· Nuance Communications, Inc.; Eon;
Koninklijke Philips N.V.; Siemens Healthineers AG; PenRad Technologies, Inc.;
MRS Systems, Inc.; and Magview are some of the key companies in the market
Grand View Research has segmented the
global lung cancer screening software market on the basis of region:
Lung Cancer Screening Software Regional
Outlook (Revenue, USD Thousand, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
U.K.
o
Germany
o
Italy
o
France
o
Spain
o
Russia
·
Asia Pacific
o
Japan
o
China
o
Australia
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Press Release of Lung Cancer Screening Software Market@ https://www.grandviewresearch.com/press-release/global-lung-cancer-screening-software-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
